Watchlist Price Alert

Albany Molecular Research... (AMRI)

NASDAQ: AMRI · Real-Time Price · USD

undefined

null (null%)

At close: Jun 28, 2019, 10:07 PM

Albany Molecular Research Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-59.77M	-70.8M	-70.17M	-52.98M	-33.72M	-10.14M
Depreciation & Amortization	76.65M	66.03M	56.71M	44.79M	38.5M	34.77M
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-331.86M	66.31M	25.93M	20.28M	-5.35M	17.69M
Other Non-Cash Items	320.09M	-42.09M	-3.63M	-12.24M	20.27M	-21.91M
Deferred Income Tax	15.37M	1.02M	-943K	1.33M	-5.93M	960K
Change in Working Capital	-342.69M	45.73M	36.24M	17.56M	7.83M	36.4M
Operating Cash Flow	19.91M	8.53M	26.64M	6.36M	34.86M	46.95M
Capital Expenditures	-36.95M	-43.75M	-51.43M	-46.33M	-39.47M	-29.54M
Cash Acquisitions	-140.96M	-142.02M	-142.02M	-198.25M	-140.98M	-140.26M
Purchase of Investments	-2.15M	-2.14M	-974K	-887K	-977K	-1.06M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	4.6M	839K	-405K	2.03M	175K	723K
Investing Cash Flow	-175.46M	-187.07M	-194.82M	-243.44M	-181.25M	-170.14M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-2.15M	-2.14M	-974K	-887K	-977K	-1.06M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	167.1M	169.54M	170.84M	202.37M	134.42M	138.4M
Financial Cash Flow	167.1M	169.54M	170.84M	202.37M	134.42M	138.4M
Net Cash Flow	11.55M	-9M	2.66M	-34.71M	-11.88M	15.68M
Free Cash Flow	-17.03M	-35.22M	-24.79M	-39.97M	-4.61M	17.41M